Scientific Industries, Inc.
SCND · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.09 | 0.54 | -0.05 | 0.12 |
| FCF Yield | -5.74% | -4.10% | -5.50% | -4.60% |
| EV / EBITDA | -11.51 | -13.20 | -17.97 | -22.93 |
| Quality | ||||
| ROIC | -14.66% | -18.30% | -18.51% | -4.86% |
| Gross Margin | 45.03% | 45.68% | 45.26% | 50.53% |
| Cash Conversion Ratio | -0.32 | 0.94 | 0.75 | 0.20 |
| Growth | ||||
| Revenue 3-Year CAGR | -6.84% | -3.40% | -2.57% | -0.10% |
| Free Cash Flow Growth | -18.67% | 40.59% | -21.35% | -10.32% |
| Safety | ||||
| Net Debt / EBITDA | -0.25 | -0.33 | -0.32 | 0.57 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.31 | 0.27 | 0.31 | 0.27 |
| Cash Conversion Cycle | 292.82 | 315.14 | 290.63 | 350.75 |